110 results found.
          
Orthopedic Public Companies Grow 2.6% YoY in Quarter
.article table {table-collapse: collapse;} .article table {border: 1px solid black !important;margin-bottom: 18px;} .artcle th {border: 1px solid black !important;} .article td {border: 1px solid black !important;} .article tr:last-child .article td {text-align: right;} ....
Mako Adoption Helps Drive Stryker to 8.1% Growth in 2Q19
Stryker reports 2Q19 revenue of USD $1,916.7MM, +8.1% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Robotics Recap: Orthopedic Executives Remain Bullish
By Mike Evers   Despite normal seasonal softness in capital sales, the first quarter of 2019 was an active one for robotic and digital surgery developments. New entrants into the orthopedic robot market like Zimmer Biomet’s ROSA Knee may lead to longer buying cycles as ...
Global Orthopedic Market Revenue to Exceed $61 Billion in 2023
The global orthopedic market will exceed US $61 billion in revenue in 2023.
Future-Minded Orthopedic and Spine Surgeons Will Advise Industry Stakeholders and Manufacturing Community at OMTEC® 2019
Future-minded orthopedic and spine surgeons will advise industry stakeholders and the manufacturing community at OMTEC® 2019
Zimmer Biomet Reports 1Q19 Orthopedic Revenue of $1,759.4MM, -2.2% vs. 1Q18
Zimmer Biomet reports 1Q19 orthopedic revenue of USD $1,759.4MM, -2.2% vs. 1Q18
Stryker reports 1Q19 orthopedic revenue of $1,881.7MM, +7.8% vs. 1Q18
Stryker reports 1Q19 orthopedic revenue of USD $1,881.7MM, +7.8% vs. 1Q18.
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Smith & Nephew Reports 4Q18 Orthopedic Revenue of $911.8MM, +1.4% vs. 4Q17
Smith & Nephew reports 4Q18 orthopedic revenue of USD $911.8MM, +1.4% vs. 4Q1...
Stryker Reports 4Q18 Orthopedic Revenue of $1,932.3MM, +6.4% vs. 4Q17
Stryker reports 4Q18 orthopedic revenue of $1,932.3MM, +6.5% vs. 4Q17, with full year revenue of ...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
K2M Reports 3Q18 Revenue of $71.4MM, +13.9% vs. 3Q17
K2M reports final quarterly results before acquisition by Stryker, posts 3Q18 revenue of $71.4MM, +13.9%
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17.
OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17
OrthoPediatrics continues growth with another quarter of record revenues, reports US $15.8MM in 3Q18 sales, +...
Stryker Reports 3Q18 Revenue of $1.6BB, +4.2% vs. 3Q17
Momentum in knee reconstruction drove Stryker’s 3Q18 orthopaedic performance, with revenue of US $1,689.7MM, +4.2% vs. 3Q1...
DePuy Synthes Reports 3Q18 Revenue, -4.2% vs. 3Q17
DePuy Synthes’ 3Q18 orthopaedic performance remains challenged with revenue of US $2,111.3MM, -4.2% vs. 3Q17.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
Spine Company Sales: ORTHOWORLD Top Ten
Spine...
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Stryker Posts 2Q18 Revenue Growth of 8% YoY
ORTHOWORLD estimates Stryker’s 2Q18 orthopaedic revenue at US $1,747.8MM, +8.0% from 2Q17, and 1H18 revenue at
DePuy Synthes Reports 2Q18 Orthopaedic Revenue -1.4% YoY
DePuy Synthes reported 2Q18 orthopaedic revenue of US $2,261.0MM, -1.4% vs. 2Q17, and 1H18 revenue of 
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group